Riverhead Capital Management’s AstraZeneca AZN Stock Holding History

Riverhead Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$357K	Buy	4,008 +1,650	+70%	+$143K	0.01%	875
2019 Q2	$195K	Buy	2,358 +389	+20%	+$30.5K	0.01%	1157
2019 Q1	$159K	Buy	1,969 +520	+36%	+$41K	0.01%	1213
2018 Q4	$110K	Sell	1,449 -3,301	-69%	-$258K	﹤0.01%	1277
2018 Q3	$376K	Hold	4,750	–	–	0.01%	898
2018 Q2	$334K	Hold	4,750	–	–	0.01%	849
2018 Q1	$332K	Hold	4,750	–	–	0.01%	835
2017 Q4	$330K	Hold	4,750	–	–	0.01%	848
2017 Q3	$322K	Hold	4,750	–	–	0.02%	775
2017 Q2	$324K	Hold	4,750	–	–	0.02%	746
2017 Q1	$296K	Hold	4,750	–	–	0.02%	674
2016 Q4	$260K	Hold	4,750	–	–	0.02%	660
2016 Q3	$312K	Sell	4,750 -5,678	-54%	-$371K	0.02%	582
2016 Q2	$630K	Sell	10,428 -20,145	-66%	-$1.17M	0.02%	554
2016 Q1	$1.72M	Sell	30,573 -1,027	-3%	-$61.7K	0.02%	559
2015 Q4	$2.15M	Hold	31,600	–	–	0.03%	506
2015 Q3	$2.01M	Hold	31,600	–	–	0.03%	476
2015 Q2	$2.01M	Hold	31,600	–	–	0.03%	475
2015 Q1	$2.16M	Hold	31,600	–	–	0.03%	470
2014 Q4	$2.22M	Hold	31,600	–	–	0.03%	461
2014 Q3	$2.26M	Hold	31,600	–	–	0.04%	440
2014 Q2	$2.35M	Hold	31,600	–	–	0.04%	411
2014 Q1	$2.05M	Buy	+31,600	New	+$2.04M	0.04%	397
2013 Q3	–	Sell	-42,000	Closed	-$1.99M	–	426
2013 Q2	$1.99M	Buy	+42,000	New	+$2.14M	0.07%	278

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Riverhead Capital Management's AZN Position: Q3 2019 in Review

Riverhead Capital Management increased its AstraZeneca (AZN) stake by 70% in Q3 2019, buying an estimated $143K and bringing the position to 4,008 shares worth $357K. The position accounts for 0.01% of the portfolio, ranked #875.

Riverhead Capital Management first reported a position in AZN in Q2 2013 and has held it in 24 quarters since. The position peaked at $2.35M in Q2 2014. 555 funds tracked by Wall St. Rank hold AZN as of Q3 2019.

Riverhead Capital Management held 4,008 shares of AstraZeneca worth $357K as of Q3 2019.
Riverhead Capital Management bought 1,650 AstraZeneca shares in Q3 2019, an estimated $143K.
AstraZeneca made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #875 holding.
Riverhead Capital Management first reported a position in AstraZeneca in Q2 2013 and has held it in 24 quarters since.
Riverhead Capital Management's AstraZeneca position peaked at $2.35M in Q2 2014.
555 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.